Arkolith/Insider Trading/DSGN/Form 4

Quan Venture Fund II, L.P.

10% OwnerDesign Therapeutics, Inc. (DSGN) · full profile →Form 4 · filed Apr 1, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 30, 2021Conversion(C)4.4M——4.4M
Mar 30, 2021Conversion(C)281K——4.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 30, 2021Conversion(C)458K——0
Mar 30, 2021Conversion(C)7.2M——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-024242) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML